Please find below the details of upcoming IPO Laxmi Organic Industries Limited.

Laxmi Organic Industries Limited
Company Details ·  Laxmi Organic Industries Limited is a leading manufacturer of Acetyl Intermediates and Specialty Intermediates

with almost three decades of experience in large scale manufacturing of chemicals. Since their inception in 1989,

Company has been on a journey of transformation.

·  Company is currently among the largest manufacturers of ethyl acetate in India with a market share of

approximately 30% of the Indian ethyl acetate market (source: Frost & Sullivan Report). Further, post completion of

the YCPL Acquisition, their market share in the ethyl acetate market will be further enhanced.

·  Company is the only manufacturer of diketene derivatives in India with a market share of approximately 55 % of the

Indian diketene derivatives market in terms of revenue in Fiscal 2020 and one of the largest portfolios of diketene

products (source: Frost & Sullivan Report).

·  Company’s products are currently divided into two broad categories, namely the Acetyl Intermediates and the

Specialty Intermediates. The Acetyl Intermediates include ethyl acetate, acetaldehyde, fuel-grade ethanol and other

proprietary solvents, while the Specialty Intermediates comprises of ketene, diketene derivatives namely esters,

acetic anhydride, amides, arylides and other chemicals. Company’s products find application in various high-growth

industries, including pharmaceuticals, agrochemicals, dyes & pigments, inks & coatings, paints, printing &

packaging, flavours & fragrances, adhesives and other industrial applications.

· Over the years, they have significantly expanded their scale of operations and global footprint with customers in over

30 countries including China, Netherlands, Russia, Singapore, United Arab Emirates, United Kingdom and United

States of America. Company have offices in Leiden (Netherlands), Shanghai (China) and Sharjah (United Arab

Emirates) which enables them to assess international demand and increase their customer outreach thereby

bolstering their product development initiatives.

· Company currently have two manufacturing facilities in Mahad, Maharashtra (the “Manufacturing Facilities”), with

one facility dedicated to Acetyl Intermediates (the “AI Manufacturing Facility”) and another dedicated to Specialty

Intermediates (the “SI Manufacturing Facility”). They also have two distilleries located in Satara district (the

“Jarandeshwar Distillery”) and Kolhapur district in Maharashtra (the “Panchganga Distillery”). Company have two

Department of Scientific and Industrial Research, Government of India (“DSIR”) recognized research and development

facilities, with state-of-the-art research and development infrastructure to synthesise specialty molecules and

advanced intermediates (source: Frost & Sullivan Report).

Issue Period Monday, March 15th, 2021
Wednesday, March 17th, 2021.
Price Band Rs.129/- to Rs.130/- per equity shares.
Bid Lot 115 Equity share and in multiple of 115 equity share thereafter.
Issue Size Rs. 600.00 Cr.
Issue break-up QIB  – 50 % of the offer –  Rs. 300.00 Cr
NIB  – 15 % of the offer –  Rs.   90.00 Cr
RET –  35 % of the offer –  Rs. 210.00 Cr
Listing BSE & NSE
Registrar Link Intime India Private Limited
UPI All Retail Applications through brokers are compulsorily in UPI Mode

Company Financials:

Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in millions)
30-Sep-20 31-Mar-20 31-Mar-19 31-Mar-18
Total Assets 10,371.32 10,706.33 10,144.88 8,947.34
Total Revenue 8,143.55 15,386.21 15,743.23 13,960.75
Profit After Tax 454.84 702.12 723.91 756.95

Objects of the Issue:

  • Investment in subsidiary firm, Yellowstone Fine Chemicals Private Limited (YFCPL) to partly finance the capex to establish a new manufacturing facility.
  • To invest in YFCPL for financing working capital requirements.
  • To finance the capex for expansion of SI manufacturing facility.
  • To finance business working capital requirements.
  • To purchase plant and machinery for infrastructure development at SI facility.
  • To make prepayment or repayment of borrowings availed by the company and subsidiary, Viva Lifesciences Pvt Ltd (VLPL).
  • To meet general corporate purposes.

Laxmi Organic IPO Date & Price Band:

 IPO Open:  15 March 2021
 IPO Close:  17 March 2021
 IPO Size:  Approx ₹600 Crore
 Face Value:  ₹2 Per Equity Share
 Price Band:  ₹129 to ₹130 Per Share
 Listing on:  BSE & NSE
 Retail Portion:  35%
 Equity:  55,43,052 Shares

Laxmi Organic IPO Market Lot:

 Minimum Lot Size:  Minimum 115 Shares
 Minimum Amount:  ₹14950
 Maximum Lot Size:  Maximum 1495 Shares
 Maximum Amount:  ₹194350

Laxmi Organic IPO Allotment & Listing:

 Basis of Allotment:  22 March 2021
 Refunds:  23 March 2021
 Credit to Demat Account:  24 March 2021
 Listing Date:  25 March 2021

Laxmi Organic IPO Review:

  • Apply for Listing Gain and Long Term Gain